Service use and treatment barriers among inhalant users

Brian E. Perron, Orion Mowbray, Sarah Bier, Michael G. Vaughn, Amy Krentzman, Matthew O. Howard

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Inhalant use is a serious global problem with consequences equal to or surpassing those of other drugs. Regrettably, few prior studies have examined inhalant users' patterns of service and treatment utilization. The purpose of this study is to identify factors associated with service use and barriers to treatment among a nationally representative sample of inhalant users. Data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) reveal that among inhalant users problem severity and substance use disorder comorbidity were associated with substance abuse treatment barriers and service usage. These findings can help improve the service delivery system to provide effective treatments and reduce the risk of emergency department usage, which is among the most expensive and least effective ways to deal with substance abuse.

Original languageEnglish (US)
Pages (from-to)69-75
Number of pages7
JournalJournal of Psychoactive Drugs
Issue number1
StatePublished - Jan 2011

Bibliographical note

Funding Information:
†This research was supported by grants DA027832 (Perron) and AA019575 (Perron) from the U.S. National Institutes of Health (NIH). The NIH had no role in the design or conduct of the study, collection, management, analysis and interpretation of the data, or preparation, review or approval of the manuscript. *Assistant Professor, University of Michigan, School of Social Work, Ann Arbor, MI. **Doctoral student, University of Michigan Joint Program in Social Work and Psychology, Ann Arbor, MI. ***Graduate student and research assistant, University of Michigan School of Social Work, Ann Arbor, MI.


  • Inhalant misuse
  • Service utilization
  • Substance abuse treatment
  • Treatment barriers


Dive into the research topics of 'Service use and treatment barriers among inhalant users'. Together they form a unique fingerprint.

Cite this